As a consequence, for men harboring BRCA1/2 PVs, despite the increasing knowledge on gene-specific cancer phenotype differences to guide surveillance programs [155], there is no consensus on the best follow-up strategy for these individuals, and guidelines diverge based on recommendations (Table 3). Here, BRCA1 is linked to cancer.